Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) Under Investigation for Investors over Takeover
The acquisition of Ariad Pharmaceuticals, Inc. is under investigation over possible wrongdoing. The investigation was announced for, who currently hold NASDAQ:ARIA shares, concerning whether the takeover of Ariad Pharmaceuticals, Inc. by Takeda Pharmaceutical Company Limited for $24.00 per share is unfair.
View full press release